Post-COVID Lung Disease Shares Origins with Other Scarring Lung Disorders
UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
With a $45 million grant from the NIH, UC San Diego researchers and collaborators will launch a nationwide clinical trial to further investigate the therapeutic potential of benfotiamine, a synthetic version of thiamine (B1), as a treatment for Alzheimer’s disease.
While many U.S. policy makers are calling for reshoring and nearshoring to combat trade disruptions caused by COVID-19, new University of California San Diego School of Global Policy and Strategy research suggests retrenchment of global supply chains is unlikely to happen.
UC San Diego researchers tracked the evolution of a gene variant that supports cognitive health in older humans, but may have first emerged to protect against bacteria.
The University of California San Diego has reached the conclusion of its landmark Campaign for UC San Diego, raising a total of $3.05 billion in philanthropic support over a span of 10 years.
Scientists have uncovered an intriguing new understanding of how viruses and the hosts they infect evolve new innovations to outcompete each other. Culminating a 10-year research effort, the researchers tracked the way fitness landscapes constantly change in the ongoing struggle for survival.
VICE, August 28
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.